Printer Friendly

REGNIER, PH.D NAMED CHIEF TECHNICAL OFFICER OF PERSEPTIVE BIOSYSTEMS; CO-INVENTOR OF PERFUSION CHROMATOGRAPHY WILL LEAD TECHNOLOGY EFFORTS

 CAMBRIDGE, Mass., Jan. 5 /PRNewswire/ -- Fred E. Regnier, Ph.D., an internationally renowned academic leader in the field of bio-analytical chemistry and development of novel separations technologies, will take a leave absence from his post as Professor of Chemistry at Purdue University to become acting chief technical officer of PerSeptive Biosystems, Inc. (NASDAQ PBIO), the company announced today. As chief technical officer, Regnier will oversee the research and development of PerSeptive's core technologies for the purification and analysis of biomolecules as well as applications of these core technologies being pursued by PerSeptive's independent R&D entity, PerSeptive Technologies II Corporation (NASDAQ: PTCCZ).
 Among his many achievements, Regnier is co-inventor of Perfusion Chromatography(R) with Noubar B. Afeyan, Ph.D., president and CEO of PerSeptive Biosystems. Regnier is also a company co-founder and chairman of the scientific advisory board. Regnier began his new position Jan. 3, 1994.
 Afeyan commented, "Fred has already played a critical role in the development of our novel technologies for the purification and analysis of biomolecules. As chief technical officer, he will be able to dedicate his tremendous expertise to moving our development programs forward to their next level. Fred's vast expertise and research leadership in the field of bio-analytical chemistry will be invaluable as we develop new products and technologies for the Life Sciences research labs and industry.
 Afeyan continued, "Fred is one of the foremost researchers in the field of bio chromatography today. We are excited about the contributions he will make in this new capacity with PerSeptive, particularly in his target research areas including capillary electrophoresis, surface chemistries and immunoassay." In addition to his new roles as chief technical officer, Regnier will continue as chairman of the scientific advisory board. The PerSeptive R&D organization currently includes more than 80 scientists and engineers focusing on disciplines such as protein and DNA chemistry, molecular biology, polymer chemistry, computer software, chemical, mechanical and electrical engineering. The company intends to approximately double the size of its R&D organization over the next year.
 A renowned researcher in the separations field, Regnier is the author of over 200 publications and more than 20 patents on various aspects of chemistry, biochemistry and separations techniques and their applications to proteins. Regnier has received the David B. Hime Award for Achievements in Chromatography, the Stephen Dal Nogare Award for Achievements in Chromatography, the American Chemical Society Award in Chromatography and The Martin Gold Medal Award for distinguished contributions to Separation Science of Biopolymers presented by the Chromatographic Society in 1993. He serves on the editorial boards of "The Journal of Chromatography", "Liquid Chromatography Magazine" and "Analytical Methods and Instrumentation".
 Regnier has held a number of positions in chemistry and biochemistry at Purdue University for the past 20 years. Prior to his current position as Professor of Chemistry, he was Professor of Biochemistry, Professor, Associate Professor and Associate Director of the Agricultural Experiment Station.
 Regnier has a B.S. degree in Chemistry from Nebraska State College and a Ph.D. degree in Chemistry from Oklahoma State University. His postdoctoral research was done at Oklahoma State, the University of Chicago and Harvard University.
 PerSeptive Biosystems designs, manufactures and markets proprietary products and systems for the purification and analysis of biomolecules. These bioseparations products significantly reduce the time and cost required for the development and manufacture of biopharmaceuticals. The company's current and planned products for the purification and analysis of biomolecules are based on three interrelated core technologies: Perfusion Chromatography for high resolution separations of biomolecules ten to one thousand times faster than conventional chromatography; ImmunoDetection(TM) for real-time immunoassays in a flow-through cartridge format; and Rational Surface Design(TM), synthetic surfaces that bind biomolecules with the high specificity of antibodies.
 -0- 1/5/94
 /CONTACT: Noubar B. Afeyan, Ph.D., president and CEO of PerSeptive Biosystems, 617-621-1787/
 (PBTO PTCCZ)


CO: PerSeptive Biosystems, Inc.; PerSeptive Technologies II Corporation ST: Massachusetts IN: MTC SU: PER

JL-CM -- NE009 -- 9281 01/05/94 10:53 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 5, 1994
Words:659
Previous Article:BORGES ELECTED TO SHAWMUT BANK BOARD
Next Article:COLONIAL CLOSED-END FUNDS ISSUE DISTRIBUTION DECLARATION
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters